Tax Planning Webinars: Optimize Your 2026-2027 Tax Strategy
Registration is now open for AAFCPAs’ highly anticipated annual tax webinars!
Registration is now open for AAFCPAs’ highly anticipated annual tax webinars!
The tax landscape continues to evolve, creating both opportunities and planning considerations for life sciences companies at every stage of growth.
Stay ahead of tax, compliance, and operational developments that may influence business performance and growth.
Interest is rising in life‑science pipelines, and companies that succeed combine strong science with disciplined financial and operational foundations.
For decades, companies have navigated the complexities involved in deducting research and experimental expenditures. The One Big Beautiful Bill (OBBB) Act with the newly released...
Life sciences companies face some of the highest costs and longest timelines for research and development. The One Big Beautiful Bill (OBBB) Act, with the...
Understanding the U.S. Market Entry Process for Life Science Companies For foreign life sciences companies, the decision to establish a presence in the United States...
The One Big Beautiful Bill Act (OBBBA), enacted in July 2025, introduces broad changes to international tax rules. These adjustments will affect U.S. corporations with...
Life science companies, particularly those in the start-up or growth phase, are challenged with balancing their core mission, e.g., advancing scientific discovery, with the complex...